269 related articles for article (PubMed ID: 29675884)
1. Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.
Zhang S; Wang Y; Gu Y; Zhu J; Ci C; Guo Z; Chen C; Wei Y; Lv W; Liu H; Zhang D; Zhang Y
Mol Oncol; 2018 Jun; 12(7):1047-1060. PubMed ID: 29675884
[TBL] [Abstract][Full Text] [Related]
2. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
3. A DNA methylation-based definition of biologically distinct breast cancer subtypes.
Stefansson OA; Moran S; Gomez A; Sayols S; Arribas-Jorba C; Sandoval J; Hilmarsdottir H; Olafsdottir E; Tryggvadottir L; Jonasson JG; Eyfjord J; Esteller M
Mol Oncol; 2015 Mar; 9(3):555-68. PubMed ID: 25468711
[TBL] [Abstract][Full Text] [Related]
4. Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Chen X; Zhao C; Zhao Z; Wang H; Fang Z
Front Genet; 2019; 10():786. PubMed ID: 31572431
[TBL] [Abstract][Full Text] [Related]
5. Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation.
Liu Y; Gu Y; Zhang M; Zeng J; Wang Y; Wang H; Liu X; Liu S; Wang Z; Wang Y; Wang L; Zhang Y
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421781
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Yang C; Zhang Y; Xu X; Li W
Aging (Albany NY); 2019 Dec; 11(24):11880-11892. PubMed ID: 31852837
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
Chen H; Qin Q; Xu Z; Chen T; Yao X; Xu B; Sun X
J Cell Physiol; 2021 Mar; 236(3):2126-2138. PubMed ID: 32830322
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups.
Chen W; Zhuang J; Wang PP; Jiang J; Lin C; Zeng P; Liang Y; Zhang X; Dai Y; Diao H
Cancer Cell Int; 2019; 19():185. PubMed ID: 31346320
[TBL] [Abstract][Full Text] [Related]
9. Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.
Ma H; Zhao C; Zhao Z; Hu L; Ye F; Wang H; Fang Z; Wu Y; Chen X
Cancer Gene Ther; 2020 Sep; 27(9):702-714. PubMed ID: 31619751
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
Wu ZH; Tang Y; Zhou Y
Cancer Control; 2021; 28():1073274820988519. PubMed ID: 33504182
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiles capturing breast cancer heterogeneity.
Chen X; Zhang J; Dai X
BMC Genomics; 2019 Nov; 20(1):823. PubMed ID: 31699026
[TBL] [Abstract][Full Text] [Related]
12. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
[TBL] [Abstract][Full Text] [Related]
14. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines.
Chae H; Lee S; Nephew KP; Kim S
BMC Syst Biol; 2016 Dec; 10(Suppl 4):116. PubMed ID: 28155687
[TBL] [Abstract][Full Text] [Related]
16. Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment.
Wang Y; Zhang Y; Huang Y; Chen C; Zhang X; Xing Y; Gu Y; Zhang M; Cai L; Xu S; Sun B
Theranostics; 2021; 11(9):4403-4420. PubMed ID: 33754068
[No Abstract] [Full Text] [Related]
17. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Li C; Ke J; Liu J; Su J
J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
[TBL] [Abstract][Full Text] [Related]
18. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.
Bian J; Long JY; Yang X; Yang XB; Xu YY; Lu X; Sang XT; Zhao HT
World J Gastroenterol; 2020 Nov; 26(41):6414-6430. PubMed ID: 33244202
[TBL] [Abstract][Full Text] [Related]
19. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
[TBL] [Abstract][Full Text] [Related]
20. Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
Fernandez-Jimenez N; Sklias A; Ecsedi S; Cahais V; Degli-Esposti D; Jay A; Ancey PB; Woo HD; Hernandez-Vargas H; Herceg Z
Epigenetics; 2017; 12(11):964-972. PubMed ID: 29099283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
